HELLENIC DYNAMICS PLC Logo

HELLENIC DYNAMICS PLC

Cultivates and supplies THC-dominant medical cannabis for the European pharmaceutical market.

HELD | IL

Overview

Corporate Details

ISIN(s):
GB00BRXCFB77
LEI:
213800IM978BOB5QZA69
Country:
United Kingdom
Address:
21 ARLINGTON STREET, SW1A 1RN LONDON
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Hellenic Dynamics PLC is a licensed cultivator and supplier of pharmaceutical-standard medical cannabis products, specializing in THC-dominant strains. Founded in 2018, the company operates a large-scale cultivation and production facility near Thessaloniki, Greece, with significant capacity for dried cannabis flowers and extracts. Its license allows for unlimited production, export, and THC content. The company's primary target is the European medical market, with an initial focus on Germany, where its first production phase was pre-sold to licensed distributors. Hellenic Dynamics aims to become a dominant European supplier by offering high-quality, competitively priced products and developing a proprietary, IP-protected library of THC genetics through research partnerships.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-02-12 18:45
Legal Proceedings Report
Further re: Winding-Up Petition
English 14.4 KB
2024-12-19 12:35
Legal Proceedings Report
Further re: Winding-Up Petition
English 11.7 KB
2024-11-26 11:00
Legal Proceedings Report
Winding-Up Petition
English 11.8 KB
2024-11-15 08:00
Capital/Financing Update
Update on €1 million loan
English 11.4 KB
2024-11-11 14:30
Regulatory News Service
Change of Registered Office
English 9.0 KB
2024-10-07 08:00
Capital/Financing Update
Update on receipt of €1 million loan
English 10.5 KB
2024-08-21 16:30
Capital/Financing Update
Update on receipt of €1 million loan
English 10.4 KB
2024-08-14 08:00
Legal Proceedings Report
Update on Petition and Related Party Transactions
English 14.6 KB
2024-08-01 14:10
Legal Proceedings Report
Winding-Up Petition
English 10.8 KB
2024-08-01 09:00
Delisting Announcement
Delay to the publication of accounts & Suspension
English 12.7 KB
2024-07-15 08:00
Share Issue/Capital Change
Settlement of Fees and Issue of Equity
English 15.4 KB
2024-07-08 11:30
Major Shareholding Notification
Holding(s) in Company
English 52.3 KB
2024-07-02 16:18
Major Shareholding Notification
Holding(s) in Company
English 52.7 KB
2024-07-02 11:45
Regulatory News Service
Facility, Cultivation and Market Update
English 31.4 KB
2024-06-25 08:00
Board/Management Information
Directorate Changes
English 13.9 KB

Automate Your Workflow. Get a real-time feed of all HELLENIC DYNAMICS PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for HELLENIC DYNAMICS PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
2cureX AB Logo
Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.
Sweden 2CUREX
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
4SC AG Logo
Developing small-molecule epigenetic drugs for high-need cancer indications.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.
Sweden ABERA
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
Abliva Logo
Develops clinical-stage medicines for rare primary mitochondrial diseases to restore cell function.
Sweden ABLI
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
Access Bio, Inc. Logo
Develops and manufactures rapid diagnostic tests for infectious diseases for global health.
United States of America 950130
Active Biotech Logo
Develops immunology-based drugs for cancer and inflammatory diseases with high unmet medical need.
Sweden ACTI

Talk to a Data Expert

Have a question? We'll get back to you promptly.